# Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

> **NCT00692185** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 23 (actual)

## Conditions studied

- Eating Disorders

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00692185
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692185, "Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00692185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*